MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Xiong, Yin ^a   Zhang, Lisa ^a   Holloway, Alisha K ^b   Wu, Xiaolin ^c   Su, Ling ^c   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 20A; MICRORNA 886 3P; UNCLASSIFIED DRUG; MIRN886 MICRORNA, HUMAN; RNA PRECURSOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLOGY; DNA REPLICATION; DOWN REGULATION; FAMILIAL THYROID PAPILLARY CARCINOMA; FOCAL ADHESION; GENE CONTROL; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPORADIC THYROID PAPILLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR SPHEROID; CELL CYCLE; CELL MOTION; FAMILIAL CANCER; FEMALE; GENETICS; GENOMICS; MALE; METABOLISM; MULTICELLULAR SPHEROID; NUCLEOTIDE SEQUENCE; PATHOLOGY; THYROID TUMOR; TUMOR CELL LINE;

BASE SEQUENCE; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA REPLICATION; DOWN-REGULATION; FEMALE; FOCAL ADHESIONS; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MALE; MICRORNAS; NEOPLASTIC SYNDROMES, HEREDITARY; RNA PRECURSORS; SPHEROIDS, CELLULAR; THYROID NEOPLASMS;

EID: 80053604708     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024717     Document Type: Article

References (49)

1. Chen AY, Jemal A, Ward EM, (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115: 3801-3807.
2. Vriens MR, Suh I, Moses W, Kebebew E, (2009) Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid 19: 1343-1349.
3. Ito Y, Kakudo K, Hirokawa M, Fukushima M, Yabuta T, et al. (2009) Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 145: 100-105.
4. Frich L, Glattre E, Akslen LA, (2001) Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway. Cancer Epidemiol Biomarkers Prev 10: 113-117.
5. Ron E, Kleinerman RA, LiVolsi VA, Fraumeni JF, (1991) Familial nonmedullary thyroid cancer. Oncology 48: 309-311.
6. Moses W, Weng J, Kebebew E, (2011) Prevalence, Clinicopathologic Features, and Somatic Genetic Mutation Profile in Familial Versus Sporadic Nonmedullary Thyroid Cancer. Thyroid 21: 367-71.
7. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, et al. (1998) A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63: 1743-1748.
8. McKay JD, Thompson D, Lesueur F, Stankov K, Pastore A, et al. (2004) Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. J Med Genet 41: 407-412.
9. Bonora E, Evangelisti C, Bonichon F, Tallini G, Romeo G, (2006) Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas. Br J Cancer 95: 1529-1536.
10. Prazeres HJ, Rodrigues F, Soares P, Naidenov P, Figueiredo P, et al. (2008) Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam Cancer 7: 141-149.
11. Cavaco BM, Batista PF, Sobrinho LG, Leite V, (2008) Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. J Clin Endocrinol Metab 93: 4426-4430.
12. He H, Nagy R, Liyanarachchi S, Jiao H, Li W, et al. (2009) A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69: 625-631.
13. Suh I, Filetti S, Vriens MR, Guerrero MA, Tumino S, et al. (2009) Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families. Surgery 146: 1073-1080.
14. Cavaco BM, Batista PF, Martins C, Banito A, do Rosario F, et al. (2008) Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 15: 207-215.
15. Lupoli G, Vitale G, Caraglia M, Fittipaldi MR, Abbruzzese A, et al. (1999) Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353: 637-639.
16. Robenshtok E, Tzvetov G, Grozinsky-Glasberg S, Shraga-Slutzky I, Weinstein R, et al. (2011) Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid 21: 43-48.
17. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105: 7269-7274.
18. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, et al. (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30: e15.
19. Smyth GK, Speed T, (2003) Normalization of cDNA microarray data. Methods 31: 265-273.
20. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
21. Smyth GK, (2005) limma: Linear Models for Microarray Data. In: Gentleman RobertVJC, Huber Wolfgang, Irizarry RafaelA, Dudoit Sandrine, editors. Bioinformatics and Computational Biology Solutions Using R and Bioconductor New York Springer pp. 397-420.
22. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate- a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
23. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, et al. (2008) Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93: 4331-4341.
24. Arcinas A, Yen TY, Kebebew E, Macher BA, (2009) Cell surface and secreted protein profiles of human thyroid cancer cell lines reveal distinct glycoprotein patterns. J Proteome Res 8: 3958-3968.
25. Kebebew E, Wong MG, Siperstein AE, Duh QY, Clark OH, (1999) Phenylacetate inhibits growth and vascular endothelial growth factor secretion in human thyroid carcinoma cells and modulates their differentiated function. J Clin Endocrinol Metab 84: 2840-2847.
26. van Staveren WC, Solis DY, Hebrant A, Detours V, Dumont JE, et al. (2009) Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta 1795: 92-103.
27. Borlado LR, Mendez J, (2008) CDC6: from DNA replication to cell cycle checkpoints and oncogenesis. Carcinogenesis 29: 237-243.
28. Hemminki K, Li X, Czene K, (2004) Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer 108: 109-114.
29. Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M, et al. (2010) Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102: 376-382.
30. Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, et al. (2008) miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 215: 13-20.
31. Theodore SC, Rhim JS, Turner T, Yates C, (2010) MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. Ethn Dis 20: S1-96-100.
32. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726.
33. Joglekar MV, Joglekar VM, Hardikar AA, (2009) Expression of islet-specific microRNAs during human pancreatic development. Gene Expr Patterns 9: 109-113.
34. Pesta M, Klecka J, Kulda V, Topolcan O, Hora M, et al. (2010) Importance of miR-20a expression in prostate cancer tissue. Anticancer Res 30: 3579-3583.
35. Avissar M, Christensen BC, Kelsey KT, Marsit CJ, (2009) MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15: 2850-2855.
36. Clay-Farrace L, Pelizon C, Santamaria D, Pines J, Laskey RA, (2003) Human replication protein Cdc6 prevents mitosis through a checkpoint mechanism that implicates Chk1. EMBO J 22: 704-712.
37. Xu W, Wang P, Petri B, Zhang Y, Tang W, et al. (2010) Integrin-induced PIP5K1C kinase polarization regulates neutrophil polarization, directionality, and in vivo infiltration. Immunity 33: 340-350.
38. Brown MC, Turner CE, (2004) Paxillin: adapting to change. Physiol Rev 84: 1315-1339.
39. Hervy M, Hoffman L, Beckerle MC, (2006) From the membrane to the nucleus and back again: bifunctional focal adhesion proteins. Curr Opin Cell Biol 18: 524-532.
40. Decraene C, Garcon L, Lacout C, Sabri S, Auffray C, et al. (2004) Zyxin is up-regulated during megakaryocytic differentiation of human UT-7/c-mpl cells. Biochem Biophys Res Commun 318: 439-443.
41. Cattaruzza M, Lattrich C, Hecker M, (2004) Focal adhesion protein zyxin is a mechanosensitive modulator of gene expression in vascular smooth muscle cells. Hypertension 43: 726-730.
42. Zaidel-Bar R, Ballestrem C, Kam Z, Geiger B, (2003) Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells. J Cell Sci 116: 4605-4613.
43. Mori M, Nakagami H, Koibuchi N, Miura K, Takami Y, et al. (2009) Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis. Mol Biol Cell 20: 3115-3124.
44. Yu YP, Luo JH, (2006) Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin. Cancer Res 66: 7414-7419.
45. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 1129-1139.
46. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, et al. (2009) Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-1075.
47. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, et al. (2009) Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24: 652-657.
48. Fan X, Liu Y, Jiang J, Ma Z, Wu H, et al. (2010) miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) 42: 318-324.
49. Menon MP, Khan A, (2009) Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications. J Clin Pathol 62: 978-985.